Closes 31 December 2026
What is this project about?
This study aims to understand the attitudes of Australian psychologists and educational leaders towards the psychologist psychopharmacology authority (RxP), given there is a dearth of published
literature on this topic.
Psychologists providing consultation on, or prescribing pharmacotherapies have yet to be trialled in Australia. This is despite RxP having been first trialled in the US over 30 years ago in the Defence department’s Psychopharmacology Demonstration Project (PDP) (Curtis et al., 2023), and is currently enacted in seven states (Colorado, Idaho, Illinois, Iowa, Louisiana, New Mexico, and Utah) (American Psychological Association, 2024). In the UK, a British Psychological Society (BPS) task force investigated whether that organisation should support and advocate for psychologist prescribing. The task force, which surveyed psychologists and the general public, recommended in 2020 that the BPS position should support psychologist prescribing (The British Psychological Society, 2020); however, this is yet to be implemented. Independent and unrestricted RxP has both proponents and critics existing within the discipline of psychology itself, in addition to external disciplines, most notably medicine. Advocates argue that RxP improves access to psychotropic medication (particularly in areas with few or no psychiatrists) and that prescribing psychologists integrate psychotherapy alongside medication interventions (Linda & McGrath, 2017). Medical opposition to increased psychologist scope centres around training requirements and the contention that a medical qualification is the foundation for safe prescribing (Caccavale, 2002). Within psychology, debate exists as to whether the act of prescribing medicines changes the core nature of practicing psychology and psychotherapy, pulling the profession closer to a medical model of working (Horton et al., 2024).
What does this project involve?
We will seek to recruit from a range of professional experience levels in Australia, including provisionally registered intern/student psychologists, generally registered (fully qualified) psychologists, and clinical psychology program directors and academic heads of schools in universities.
Participants will be asked to complete an online survey about their demographic and clinical background and attitudes towards various aspects of the RxP process.
To participate click on the "Start the survey" link below or for further information see contacts below.
Contact Dr Daniel Sullivan ([email protected]) or Dr Mark Boschen ([email protected]).
Start the survey